Multitarget stool DNA test (Cologuard) This combines testing for ... colon cancer tests require you to collect some of your poop, package it up, and send it to a lab or your doctor's office.

Medically reviewed by Steffini Stalos, DOFact checked by Nick BlackmerMedically reviewed by Steffini Stalos, DOFact checked ...

That’s why timely screening should be part of your regular health check-upPurdue University’s Center for Healthy Living (CHL), in conjunction with Cologuard® and Exact Sciences, is providing no-cost, ...

The FDA has approved the Cologuard Plus test for colorectal cancer screening in adults aged 45 years at average risk for colorectal cancer. The Food and Drug Administration (FDA) has approved the ...

The blood is tested for biomarkers and DNA mutations that are present with cancer. Another option, Cologuard, can be done at home — you collect a sample of your stool and mail it to a lab with ...

The maker of the Cologuard colon cancer screening test lowered its full-year outlook. CEO Kevin Conroy said the firm's quarterly execution and forecast don't reflect its full potential.

Cologuard Plus™ test raises the performance bar with sensitivities of 95% for colorectal cancer and 43% for advanced precancerous lesions at 94% specificity Cologuard Plus test will minimize ...

Exact Sciences EXAS recently received FDA approval for its next-generation multitarget stool DNA test, Cologuard Plus. This marks a significant advancement for the company in the field of ...

With this in mind, let’s look at what’s typically included in a severance package. What is a severance package? A severance package is the pay and benefits an employee receives from an ...

An application program developed for sale to the general public. Packaged software is designed to appeal to a large audience of users, and although the programs may be tailored to a user's taste ...

Our opinions are our own. Wanting to travel but not sure where to start? Vacation packages may seem like an appealing option, especially since they can bundle together multiple bookings at once.

Exact Sciences shares plunged Wednesday after the company reported widening losses. The maker of the Cologuard colon cancer screening test lowered its full-year outlook. CEO Kevin Conroy said the ...